CUSIP: 30315R107
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,178,898
-
Share change
-
-2,424,364
-
Total reported value
-
$29,034,369
-
Price per share
-
$3.55
-
Number of holders
-
36
-
Value change
-
-$12,343,496
-
Number of buys
-
14
-
Number of sells
-
21
Quarterly Holders Quick Answers
What is CUSIP 30315R107?
CUSIP 30315R107 identifies FSTX - F-STAR THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2022
-
Previous quarter:
Q4 2021
Recent filing periods for CUSIP 30315R107:
Institutional Holders of F-STAR THERAPEUTICS INC - COM (FSTX) as of Q1 2022
As of 31 Mar 2022,
F-STAR THERAPEUTICS INC - COM (FSTX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,178,898 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, DAFNA Capital Management LLC, Russell Investments Group, Ltd., Atlas Venture Life Science Advisors, LLC, VANGUARD GROUP INC, Atlas Venture Advisors, Inc., and BlackRock Inc..
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.